Theravance Biopharma, Inc. (TBPH)
17.07
+0.04
(+0.23%)
USD |
NASDAQ |
Sep 02, 16:00
17.07
0.00 (0.00%)
After-Hours: 20:00
Theravance Biopharma Free Cash Flow : 53.73M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 53.73M |
| March 31, 2026 | 268.74M |
| December 31, 2025 | 238.50M |
| September 30, 2025 | 243.48M |
| June 30, 2025 | 244.78M |
| March 31, 2025 | 32.28M |
| December 31, 2024 | -11.87M |
| September 30, 2024 | -12.31M |
| June 30, 2024 | -9.602M |
| March 31, 2024 | -18.44M |
| December 31, 2023 | -29.48M |
| September 30, 2023 | -152.28M |
| June 30, 2023 | -171.85M |
| March 31, 2023 | -173.40M |
| December 31, 2022 | -187.56M |
| September 30, 2022 | -106.12M |
| June 30, 2022 | -130.52M |
| March 31, 2022 | -165.95M |
| December 31, 2021 | -211.26M |
| September 30, 2021 | -234.56M |
| June 30, 2021 | -267.15M |
| March 31, 2021 | -272.60M |
| December 31, 2020 | -257.02M |
| September 30, 2020 | -256.50M |
| June 30, 2020 | -222.12M |
| Date | Value |
|---|---|
| March 31, 2020 | -215.02M |
| December 31, 2019 | -241.37M |
| September 30, 2019 | -229.40M |
| June 30, 2019 | -235.55M |
| March 31, 2019 | -249.57M |
| December 31, 2018 | -120.11M |
| September 30, 2018 | -110.89M |
| June 30, 2018 | -123.16M |
| March 31, 2018 | -105.79M |
| December 31, 2017 | -203.46M |
| September 30, 2017 | -187.51M |
| June 30, 2017 | -137.23M |
| March 31, 2017 | -124.74M |
| December 31, 2016 | -101.12M |
| September 30, 2016 | -106.96M |
| June 30, 2016 | -126.78M |
| March 31, 2016 | -141.33M |
| December 31, 2015 | -171.50M |
| September 30, 2015 | -180.46M |
| June 30, 2015 | -184.64M |
| March 31, 2015 | -189.01M |
| December 31, 2014 | -178.26M |
| September 30, 2014 | -171.21M |
| June 30, 2014 | -167.55M |
| March 31, 2014 | -140.88M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Zymeworks, Inc. | -120.53M |
| Viatris, Inc. | 1.806B |
| Ocular Therapeutix, Inc. | -255.10M |
| ANI Pharmaceuticals, Inc. | 167.52M |
| Corcept Therapeutics, Inc. | 106.92M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.965M |
| Cash from Investing (Quarterly) | -60.40M |
| Cash from Financing (Quarterly) | -0.967M |
| Free Cash Flow Per Share (Quarterly) | -0.1348 |
| Free Cash Flow to Equity (Quarterly) | -5.03M |
| Free Cash Flow to Firm (Quarterly) | -6.965M |
| Free Cash Flow Yield | 6.06% |